聯網給藥裝置市場規模、份額和趨勢分析報告:按產品、給藥途徑、應用(哮喘、慢性阻塞性肺病、糖尿病管理、其他)、地區、細分市場2023-2030預測
市場調查報告書
商品編碼
1170997

聯網給藥裝置市場規模、份額和趨勢分析報告:按產品、給藥途徑、應用(哮喘、慢性阻塞性肺病、糖尿病管理、其他)、地區、細分市場2023-2030預測

Connected Drug Delivery Devices Market Size, Share & Trends Analysis Report By Product, By Route Of Administration (Parenteral, Inhalational), By Application (Asthma, COPD, Diabetes Management, Others), By Region, And Segment Forecasts, 2023 - 2030

出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

互聯給藥裝置的市場增長和趨勢

根據 Grandview Research 的一份新報告,到 2030 年,全球聯網給藥設備市場預計將達到 256.3 億美元。從 2023 年到 2030 年,該市場預計將以 23.45% 的複合年增長率增長。市場增長的主要驅動力包括提高患者服藥依從性、研發計劃以及加速遠程數字監控的需求。例如,2022 年 9 月,Ypsomed 與 Sidekick Health 合作,將自我注射模塊整合到 Sidekick 已知的數字治療解決方案中,以擴展 Ypsomed 的設備和 SmartServices 產品。這將使慢性病患者能夠通過整合 Ypsomed 的設備和 Sidekick 在數字健康行為經濟學和遊戲化方面的專業知識,獲得個性化的患者體驗,而製藥客戶將獲得集成服務和先進的數字治療管理系統。

一項技術進步是連接藥物輸送,它配備了傳感器,可以通過蜂窩、藍牙和 NFC(近場通信)網絡與服務器和應用程序進行通信和數據傳輸。這些聯網藥物輸送的主要好處之一是為患者提供提醒和依從性追蹤器,減少遵守規定用藥時間表所需的努力。這將進一步減少處方浪費,尤其是需要保險的生物注射劑。連接的藥物輸送系統還允許醫生監測患者對推薦治療的依從性並根據需要修改患者治療。例如,連接的藥物輸送設備可以幫助管理患有糖尿病和哮喘等慢性病的患者的自我藥療。未來幾年,這些因素預計將加速市場增長。

慢性阻塞性肺病、糖尿病和哮喘等慢性病的全球發病率上升預計將推動互聯給藥設備的業務發展。例如,國家醫學圖書館和國家生物技術信息中心於 2022 年 1 月發表的一項關於 2021 年糖尿病患病率估計的研究發現,2021 年 20 至 79 歲人群的疾病患病率為 10.5%,估計將增加到 12.2 2045 年的百分比。糖尿病被認為對男性和女性的影響相同,但最常見於 75 至 79 歲的人群。此外,隨著具有更大優勢的聯網給藥裝置的普及,手動給藥裝置越來越多地被取代。預計這些因素將推動相關藥物市場的增長。

全球 COVID-19 大流行產生了負面影響,增加了對醫療保健服務的需求。這正在加速重新設計醫療保健系統以改善支持和技術快速發展的趨勢。2020 年,全球大多數市場都在下滑,但儘管大多數國家條件艱難且處於封鎖狀態,但市場卻出現了前所未有的增長。鎖定限制導致對家庭護理中使用的藥物輸送系統的需求意外增加,這也增加了對聯網藥物輸送設備的需求。

這份報告,“聯網藥物輸送設備市場規模、份額和趨勢分析報告,按產品(聯網傳感器、集成聯網設備)、按給藥途徑(腸胃外、吸入)、按應用(哮喘、慢性阻塞性肺病、糖尿病管理)”, Grandview Research 客戶現在可以獲得 2022-2030 年區域和細分市場預測,也可以直接從以下渠道購買:

連接的藥物輸送設備市場報告要點

2022 年全球市場價值 48.4 億美元,預計預測期內復合年增長率為 23.45%

由於對連接傳感器的需求不斷增長,獨立組件和軟件部分將在預測期內增長,這些連接傳感器將傳統的藥物輸送設備轉換為連接的藥物輸送設備而不干擾其正常功能,即使設備是一次性的也可以重複使用。期間獲得最高的收入份額

由於智能和連接的腸外設備與傳統設備相比具有眾多優勢,預計在預測期內,腸外部分將推動市場增長。

到 2022 年,糖尿病管理以超過 36.23% 的份額佔據市場主導地位。這是由於糖尿病患病率上升、技術進步以及胰島素輸送裝置的研發等因素造成的。

預計北美將在預測期內主導市場。這是由於該地區人均醫療保健支出高、大公司的技術實力迅速增長以及越來越多地採用遠程監控藥物依從性。

目錄

第一章 調查方法和範圍

  • 市場細分和範圍
    • 估計/預測時間表
  • 調查方法
  • 信息採購
    • 購買的數據庫:
    • GVR 內部數據庫
    • 次要信息
    • 初步調查:
    • 第一次調查的內容
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 型號詳情
    • 商品流向分析
  • 二級信息列表
  • 目的

第二章執行摘要

  • 市場快照
  • 段快照
  • 競爭格局的快照

3 聯網藥物輸送設備市場:市場變量的趨勢和範圍

  • 市場系列展望
    • 母市場分析
    • 補充市場分析
  • 繪製滲透率和增長前景
  • 市場動態
    • 市場驅動力分析
    • 市場約束因素分析
    • 市場機會分析
    • 市場問題分析
  • 行業分析
    • 波特五力分析
      • 買方議價能力
      • 供應商的議價能力
      • 新進入者的威脅
      • 替代品的威脅
      • 行業競爭力:高
    • PESTEL 分析
      • 政治和法律環境
      • 經濟社會形勢
      • 環境狀況
      • 科技景觀
  • 研發及產品管線分析
  • 價格分析
  • 監管和報銷框架
  • 互聯給藥設備市場:COVID-19 影響分析

4 聯網給藥設備市場:產品分析

  • 2022 年和 2030 年產品市場份額分析
  • 聯網給藥設備市場:產品變化分析,2018-2030
    • 獨立組件和軟件
    • 集成設備

5 聯網給藥裝置市場:給藥途徑分析

  • 2022 年和 2030 年行政管理市場份額分析
  • 聯網給藥裝置市場:給藥途徑的變化分析,2018-2030
    • 腸外
    • 吸入

6 聯網給藥設備市場:應用分析

  • 2022 年和 2030 年應用市場份額分析
  • 聯網給藥設備市場:應用變化分析,2018-2030
    • 哮喘
    • 慢性阻塞性肺病
    • 糖尿病管理
    • 其他

7 互聯給藥設備市場:區域市場分析、副產品、給藥途徑、應用、分銷渠道 2018-2030(百萬美元)

  • 2022 年和 2030 年區域市場份額分析
  • 區域市場快照
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 多邊環境協定
    • 南非
    • 沙特阿拉伯

8 連接藥物輸送設備市場-競爭分析

  • Teva Respiratory, Llc
    • 公司簡介
    • 財務績效
    • 產品基準
    • 戰略舉措
  • Novo Nordisk A/S
    • 公司簡介
    • 財務績效
    • 產品基準
    • 戰略舉措
  • Phillips-Medisize, Llc
    • 公司簡介
    • 財務績效
    • 產品基準
    • 戰略舉措
  • Medtronic
    • 公司簡介
    • 財務績效
    • 產品基準
    • 戰略舉措
  • Adherium Limited
    • 公司簡介
    • 財務績效
    • 產品基準
    • 戰略舉措
  • Tandem Diabetes Care, Inc.
    • 公司簡介
    • 財務績效
    • 產品基準
    • 戰略舉措
  • Biocorp
    • 公司簡介
    • 財務績效
    • 產品基準
    • 戰略舉措
  • Propeller Health
    • 公司簡介
    • 產品基準
    • 戰略舉措
  • Ypsomed Ag
    • 公司簡介
    • 財務績效
    • 產品基準
    • 戰略舉措
  • Aptar Pharma
    • 公司簡介
    • 財務績效
    • 產品基準
    • 戰略舉措
  • 市場參與的分類
  • 公司市場分析
  • 主要公司名單
Product Code: GVR-2-68038-651-6

Connected Drug Delivery Devices Market Growth & Trends

The global connected drug delivery devices market size is expected to reach USD 25.63 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a lucrative CAGR of 23.45% from 2023 to 2030. Key factors driving the market growth include the need to increase patient medication adherence, R&D initiatives, and the acceleration of remote digital monitoring. In September 2022, Ypsomed for instance, partnered with Sidekick Health to expand Ypsomed's device and SmartServices offering by incorporating a self-injection module into Sidekick's known digital therapeutics solution. Through this, patients with chronic diseases are likely to receive a personalized patient experience due to the integration of Ypsomed's devices with Sidekick's digital health behavioral economics and gamification expertise, and pharmaceutical customers will benefit from a comprehensive service, and leading digital therapy management system.

One of the technological advancements is connected drug delivery, which has a sensor that enables communication and data transfer to servers and apps over cellular, Bluetooth, and Near Field Communication (NFC) networks. One of the main benefits of these connected drug delivery systems is that it gives patients reminders and adherence trackers, reducing the effort needed to comply with the prescribed medication schedule. This further reduces the cost of prescription waste, especially that from the increasingly popular biological injectable drugs that insurance would be required to pay for. Additionally, doctors can monitor how well their patients are adhering to their recommended therapies owing to connected drug delivery systems and change the patient's care as appropriate. For instance, connected drug delivery devices can be beneficial to manage self-medication in persons with chronic diseases like diabetes and asthma. In the upcoming years, these factors are anticipated to accelerate market growth.

Worldwide rising rates of chronic illnesses like COPD, diabetes, and asthma are anticipated to propel the business of connected drug delivery devices. For instance, according to research on estimates of diabetes prevalence for 2021 that was published in January 2022 by the National Library of Medicine and National Center for Biotechnology Information, the disease prevalence among people aged 20 to 79 in 2021 was estimated to be 10.5% and could increase to 12.2% by 2045. Diabetes is thought to affect both men and women equally, however, it is most common in people aged 75 to 79. Additionally, as connected drug delivery devices with greater advantages have become more popular, manual drug administration devices have been increasingly replaced. These factors are anticipated to fuel connected drug market growth.

The global COVID-19 pandemic has had a negative impact and raised the need for healthcare services. This has accelerated the trend of redesigning the healthcare system for improved assistance and quick growth of technology. While most global markets went down in 2020, this market showed unprecedented growth despite difficult conditions and a lockdown in most countries. Due to the lockdown restrictions, there was an unexpected rise in demand for drug delivery systems for use in-home care, which resulted in an increase in demand for connected drug delivery devices.

The report "Connected Drug Delivery Devices Market Size, Share & Trends Analysis Report, By Product (Connected Sensors, Integrated Connected Devices), By Route of Administration (Parenteral, Inhalational), By Application (Asthma, COPD, Diabetes Management), By Region, And Segment Forecasts, 2022-2030" is available now to Grand View Research customers and can also be directly purchased from

Connected Drug Delivery Devices Market Report Highlights

  • The global market was valued at USD 4.84 billion in 2022 and is expected to grow at a CAGR of 23.45% during the forecast period
  • The standalone components and software segment is expected to grow for the highest revenue share during the forecast period, owing to the increasing demand for connected sensors to transform traditional drug delivery devices into connected drug delivery devices without interfering with their normal functioning and can be reused even if the device is disposable
  • The parenteral segment is expected to drive market growth during the forecast period, owing to the numerous advantages offered by smart & connected parenteral devices over conventional ones
  • Diabetes Management dominated the market with a share of over 36.23% in 2022. This is owing to factors such as the rising prevalence of diabetes, technological advancements, and R&D in insulin delivery devices
  • North America is expected to dominate the market over the forecast period. This is due to the region's high per capita healthcare spending, rapid adoption of technology presence of key players, and growing adoption of remote monitoring for medication adherence

Table of Contents

Chapter 1 Research Methodology & Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Estimates & Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased database:
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary Research:
    • 1.3.5 Details of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
  • 1.7 List of Secondary Sources
  • 1.8 Objectives

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Landscape Snapshot

Chapter 3 Connected Drug Delivery Devices Market: Market Variables Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Analysis
    • 3.1.2 Ancillary Market Analysis
  • 3.2 Penetration And Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market Driver Analysis
    • 3.3.2 Market Restraint Analysis
    • 3.2.3 Market Opportunity Analysis
    • 3.2.4 Market Challenge Analysis
  • 3.4 Industry Analysis
    • 3.4.1 Porter's 5 Forces Analysis
      • 3.4.1.1 Bargaining Power of Buyers
      • 3.4.1.2 Bargaining Power of Suppliers
      • 3.4.1.3 Threat of New Entrants
      • 3.4.1.4 Threat of Substitutes
      • 3.4.1.5 Industry Rivalry: High
    • 3.4.2 PESTEL ANALYSIS
      • 3.4.2.1 Political & Legal Landscape
      • 3.4.2.2 Economic & Social Landscape
      • 3.4.2.3 Environmental Landscape
      • 3.4.2.4 Technology Landscape
  • 3.5 R&D/ Product Pipeline Analysis
  • 3.6 Pricing Analysis
  • 3.7 Regulatory & Reimbursement Framework
  • 3.8 Connected Drug Delivery Devices Market: Covid-19 Impact Analysis

Chapter 4 Connected Drug Delivery Devices Market: Product Analysis

  • 4.1 Product Market Share Analysis, 2022 & 2030
  • 4.2 Connected Drug Delivery Devices Market: Product movement analysis, 2018 to 2030
  • 4.3 Standalone Components & Software
    • 4.3.1 Standalone Components & Software market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.3.2 Integrated Devices
      • 4.3.2.1 Integrated Devices market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5 Connected Drug Delivery Devices Market: Route of Administration Analysis

  • 5.1 Route of Administration Market Share Analysis, 2022 & 2030
  • 5.2 Connected Drug Delivery Devices Market: Route of Administration movement analysis, 2018 to 2030
  • 5.3 Parenteral
    • 5.3.1 Parenteral market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.3.2 Inhalational
      • 5.3.2.1 Inhalational market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6 Connected Drug Delivery Devices Market: Application Analysis

  • 6.1 Application Market Share Analysis, 2022 & 2030
  • 6.2 Connected Drug Delivery Devices Market: Application movement analysis, 2018 to 2030
  • 6.3 Asthma
    • 6.3.1 Asthma market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.3.2 COPD
      • 6.3.2.1 COPD market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.3.3 Diabetes Management
      • 6.3.3.1 Diabetes Management market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.3.4 Others
      • 6.3.4.1 Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7 Connected Drug Delivery Devices Market: Regional Market Analysis, By Product, route of administration, application, distribution channel 2018 - 2030 (USD Million)

  • 7.1 Regional Market Share Analysis, 2022 & 2030
  • 7.2 Regional Market Snapshot
  • 7.3 North America
    • 7.3.1 North America Connected Drug Delivery Devices Market estimates and forecasts by countries, 2018 - 2030 (USD Million)
    • 7.3.2 U.S.
      • 7.3.2.1 U.S. Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.3 Canada
      • 7.3.3.1 Canada Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4 Europe
    • 7.4.1 Europe Connected Drug Delivery Devices Market estimates and forecasts by countries, 2018 - 2030 (USD Million)
    • 7.4.2 U.K.
      • 7.4.2.1 U.K. Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.3 Germany
      • 7.4.3.1 Germany Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.4 France
      • 7.4.4.1 France Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.5 Spain
      • 7.4.5.1 Spain Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.6 Italy
      • 7.4.6.1 Italy Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5 Asia Pacific
    • 7.5.1 Asia Pacific Connected Drug Delivery Devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.2 Japan
      • 7.5.2.1 Japan Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.3 China
      • 7.5.3.1 China Connected Drug Delivery Devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.4 India
      • 7.5.4.1 India Connected Drug Delivery Devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.5 Australia
      • 7.5.5.1 Australia Connected Drug Delivery Devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.6 South Korea
      • 7.5.6.1 South Korea Connected Drug Delivery Devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6 Latin America
    • 7.6.1 Latin America Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.2 Brazil
      • 7.6.2.1 Brazil Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.3 Mexico
      • 7.6.3.1 Mexico Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.4 Argentina
      • 7.6.4.1 Argentina Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7 MEA
    • 7.7.1 MEA Connected Drug Delivery Devices market estimates and forecasts by countries, 2018 - 2030 (USD Million)
    • 7.7.2 South Africa
      • 7.7.2.1 South Africa Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.3 Saudi Arabia
      • 7.7.3.1 Saudi Arabia Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8 Connected Drug Delivery Devices Market - Competitive Analysis

  • 8.1 Teva Respiratory, Llc
    • 8.1.1 Company Overview
    • 8.1.2 Financial Performance
    • 8.1.3 Product Benchmarking
    • 8.1.4 Strategic Initiatives
  • 8.2 Novo Nordisk A/S
    • 8.2.1 Company Overview
    • 8.2.2 Financial Performance
    • 8.2.3 Product Benchmarking
    • 8.2.4 Strategic Initiatives
  • 8.3 Phillips-Medisize, Llc
    • 8.3.1 Company Overview
    • 8.3.2 Financial Performance
    • 8.3.3 Product Benchmarking
    • 8.3.4 Strategic Initiatives
  • 8.4 Medtronic
    • 8.4.1 Company Overview
    • 8.4.2 Financial Performance
    • 8.4.3 Product Benchmarking
    • 8.4.4 Strategic Initiatives
  • 8.5 Adherium Limited
    • 8.5.1 Company Overview
    • 8.5.2 Financial Performance
    • 8.5.3 Product Benchmarking
    • 8.5.4 Strategic Initiatives
  • 8.6 Tandem Diabetes Care, Inc.
    • 8.6.1 Company Overview
    • 8.6.2 Financial Performance
    • 8.6.3 Product Benchmarking
    • 8.6.4 Strategic Initiatives
  • 8.7 Biocorp
    • 8.7.1 Company Overview
    • 8.7.2 Financial Performance
    • 8.7.3 Product Benchmarking
    • 8.7.4 Strategic Initiatives
  • 8.8 Propeller Health
    • 8.8.1 Company Overview
    • 8.8.2 Product Benchmarking
    • 8.8.3 Strategic Initiatives
  • 8.9 Ypsomed Ag
    • 8.9.1 Company Overview
    • 8.9.2 Financial Performance
    • 8.9.3 Product Benchmarking
    • 8.9.4 Strategic Initiatives
  • 8.10 Aptar Pharma
    • 8.10.1 Company Overview
    • 8.10.2 Financial Performance
    • 8.10.3 Product Benchmarking
    • 8.10.4 Strategic Initiatives
  • 8.11 Market Participation Categorization
  • 8.12 Company market position analysis
  • 8.13 List of Key Companies

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of key companies
  • Table 3 North America Connected Drug Delivery Devices market, by country, 2018 - 2030 (USD Million)
  • Table 4 North America Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 5 North America Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 6 North America Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 7 U.S. Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 8 U.S. Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 9 U.S. Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 10 Canada Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 11 Canada Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 12 Canada Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 13 Europe Connected Drug Delivery Devices market, by country, 2018 - 2030 (USD Million)
  • Table 14 Europe Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 15 Europe Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 16 Europe Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 17 U.K. Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 18 U.K. America Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 19 U.K. Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 20 Germany Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 21 Germany Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 22 Germany Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 23 France Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 24 France Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 25 France Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 26 Italy Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 27 Italy Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 28 Italy Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 29 Spain Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 30 Spain Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 31 Spain Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific Connected Drug Delivery Devices market, by country, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 36 China Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 37 China Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 38 China Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 39 Japan Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 40 Japan Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 41 Japan Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 42 India Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 43 India Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 44 India Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 45 Australia Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 46 Australia Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 47 Australia Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 48 South Korea Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 49 South Korea Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 50 South Korea Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 51 LATAM Connected Drug Delivery Devices market, by country, 2018 - 2030 (USD Million)
  • Table 52 LATAM Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 53 LATAM Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 54 LATAM Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 55 Brazil Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 56 Brazil Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 57 Brazil Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 58 Mexico Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 59 Mexico Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 60 Mexico Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 61 Argentina Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 62 Argentina Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 63 Argentina Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 64 MEA Connected Drug Delivery Devices market, by country, 2018 - 2030 (USD Million)
  • Table 65 MEA Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 66 MEA Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 67 MEA Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 68 South Africa Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 69 South Africa Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 70 South Africa Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 71 Saudi Arabia Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 72 Saudi Arabia Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 73 Saudi Arabia Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 74 Global Connected Drug Delivery Devices market, by region, 2018 - 2030 (USD Million)
  • Table 75 Global Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 76 Global Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 77 Global Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Commodity flow analysis
  • Fig. 10 Penetration & growth prospect mapping
  • Fig. 11 Market trends & outlook
  • Fig. 12 Market driver relevance analysis (Current & future impact)
  • Fig. 13 Market restraint relevance analysis (Current & future impact)
  • Fig. 14 Connected Drug Delivery Devices Market product outlook: Key takeaways
  • Fig. 15 Connected Drug Delivery Devices Market: Product movement analysis
  • Fig. 16 Global Standalone components & software market 2018 - 2030 (USD Million)
  • Fig. 17 Global Integrated devices market 2018 - 2030 (USD Million)
  • Fig. 18 Connected Drug Delivery Devices Market Route of Administration outlook: Key takeaways
  • Fig. 19 Connected Drug Delivery Devices Market: Route of Administration movement analysis
  • Fig. 20 Global Parenteral market 2018 - 2030 (USD Million)
  • Fig. 21 Global Inhalational market 2018 - 2030 (USD Million)
  • Fig. 22 Connected Drug Delivery Devices Market Application outlook: Key takeaways
  • Fig. 23 Connected Drug Delivery Devices Market: Application movement analysis
  • Fig. 24 Global Asthma market 2018 - 2030 (USD Million)
  • Fig. 25 Global COPD market 2018 - 2030 (USD Million)
  • Fig. 26 Global Diabetes Management market 2018 - 2030 (USD Million)
  • Fig. 27 Global Others market 2018 - 2030 (USD Million)
  • Fig. 28 Regional outlook, 2022 & 2030
  • Fig. 29 Regional marketplace: Key takeaways
  • Fig. 30 North America Connected Drug Delivery Devices Market by countries, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 32 Canada Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 33 Europe Connected Drug Delivery Devices market by countries, 2018 - 2030 (USD Million)
  • Fig. 34 U.K. Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 35 Germany Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 36 France Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 37 Spain Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 38 Italy Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 39 Asia Pacific Connected Drug Delivery Devices market by countries, 2018 - 2030 (USD Million)
  • Fig. 40 China Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 41 India Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 42 Australia Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 43 South Korea Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 44 Japan Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 45 Latin America Connected Drug Delivery Devices market by countries, 2018 - 2030 (USD Million)
  • Fig. 46 Brazil Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 47 Mexico Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 48 Argentina Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 49 MEA Connected Drug Delivery Devices market by countries, 2018 - 2030 (USD Million)
  • Fig. 50 South Africa Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 51 Saudi Arabia Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 52 Market Participant categorization
  • Fig. 53 Company market position analysis